Clinical Trials in Rhode Island

Browse 99 Rhode Island Medical Studies Across 916 Cities
52 Phase 3 Trial · 4619 Rhode Island Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Rhode Island

Reviewed by Michael Gill, B. Sc.

Image of Memorial Sloan Kettering Cancer Center (MSKCC) - Memorial Hospital - Oncology in New York, United States.

10 Rhode Island Clinical Trials Near Me

Top Cities for Rhode Island Clinical Trials

Los Angeles

71Active Trials

Cedars Sinai Medical CenterTop Active Site

Miami

70Active Trials

University of Miami Miller School of Medicine-Sylvester Cancer CenterTop Active Site

Rhode Island Clinical Trials by Phase of Trial

N/A Rhode Island Clinical Trials

13Active Rhode Island Clinical Trials

13Number of Unique Treatments

244Number of Active Locations

Amnioinfusion at room temperature (intervention arm)DrugSorb-ATR system Spinal Cord Stimulation (SCS)regional nodal XRT Smoking Cessation Treatment Radiation Therapy LPA+Fitbit intervention Stage 1 Strength Based Case Management (SBCM) Condition Personalized Integrated Chronotherapy Stress reactivity GORE® EXCLUDER® Conformable AAA Endoprosthesis Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI)Arthroscopic Bankart repair procedure

Most Recent Rhode Island Clinical Trials

Clinical Trial

Began Recruiting Date

Phase

Arm 1 [ART0380 monotherapy (endometrial cancer patients)] for Endometrial Cancer

9/7/2023

Phase 2

SPI-62 dose1 for Autonomous Cortisol Secretion

7/1/2023

Phase 2

CT1812 100 mg for Alzheimer's Disease

6/28/2023

Phase 2

Module 1: AZD5335 Monotherapy for Lung Adenocarcinoma

6/5/2023

Phase 1 & 2

Arm II (observation) for Breast Cancer

5/10/2023

Phase 3

About The Author

Michael Gill - B. Sc.

First Published: October 19th, 2021

Last Reviewed: August 10th, 2023

References¹ Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2. https://pubmed.ncbi.nlm.nih.gov/34473343² Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev. 2021 Sep 2;9:CD013825. doi: 10.1002/14651858.CD013825.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/34473343³ Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038. https://pubmed.ncbi.nlm.nih.gov/32171076⁴ Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum In: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038. https://pubmed.ncbi.nlm.nih.gov/32171076⁵ Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Dorée C, Hébert PC. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec 21;12:CD002042. doi: 10.1002/14651858.CD002042.pub5. Review. https://pubmed.ncbi.nlm.nih.gov/34932836⁶ Carson JL, Stanworth SJ, Dennis JA, Trivella M, Roubinian N, Fergusson DA, Triulzi D, Doree C, Hebert PC. Transfusion thresholds for guiding red blood cell transfusion. Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5. https://pubmed.ncbi.nlm.nih.gov/34932836⁷ O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12(12):CD013756. doi: 10.1002/14651858.CD013756.pub2. https://pubmed.ncbi.nlm.nih.gov/34854473⁸ O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12:CD013756. doi: 10.1002/14651858.CD013756.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/34854473⁹ Flumignan RL, Tinôco JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. https://pubmed.ncbi.nlm.nih.gov/33502773¹⁰ Flumignan RL, Tinôco JDS, Pascoal PI, Areias LL, Cossi MS, Fernandes MI, Costa IK, Souza L, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Prophylactic anticoagulants for people hospitalised with COVID-19. Cochrane Database Syst Rev. 2020 Oct 2;10:CD013739. doi: 10.1002/14651858.CD013739. Update in: Cochrane Database Syst Rev. 2022 Mar 4;3:CD013739. https://pubmed.ncbi.nlm.nih.gov/33502773